ArticleJournal of imaging informatics in medicine2026
Decision Strategies in AI-Based Ensemble Models in Opportunistic Alzheimer's Detection from Structural MRI.
Article in Journal of imaging informatics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Clinical pathways matter for multimodal deep learning in early Alzheimer's disease detection.Scientific reports · 2026Article
- AI-based prostate volume estimation from multi-planar MRI under variable acquisition protocols.European journal of radiology open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Alzheimer's disease (AD) is a neurodegenerative condition and the most common form of dementia. Recent developments in AD treatment call for robust diagnostic tools to facilitate medical decision-making. Despite progress for early diagnostic tests, there remains uncertainty about clinical use. Structural magnetic resonance imaging (MRI), as a readily available imaging tool in the current AD diagnostic pathway, in combination with artificial intelligence, offers opportunities of added value beyond symptomatic evaluation. However, MRI studies in AD tend to suffer from small datasets and consequently limited generalizability. Although ensemble models take advantage of the strengths of several models to improve performance and generalizability, there is little knowledge of how the different ensemble models compare performance-wise and the relationship between detection performance and model calibration. The latter is especially relevant for clinical translatability. In our study, we applied three ensemble decision strategies with three different deep learning architectures for multi-class AD detection with structural MRI. For two of the three architectures, the weighted average was the best decision strategy in terms of balanced accuracy and calibration error. In contrast to the base models, the results of the ensemble models showed that the best detection performance corresponded to the lowest calibration error, independent of the architecture. For each architecture, the best ensemble model reduced the estimated calibration error compared to the base model average from (1) 0.174±0.01 to 0.164±0.04, (2) 0.182±0.02 to 0.141±0.04, and (3) 0.269±0.08 to 0.240±0.04 and increased the balanced accuracy from (1) 0.527±0.05 to 0.608±0.06, (2) 0.417±0.03 to 0.456±0.04, and (3) 0.348±0.02 to 0.371±0.03.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.